Metraipolis › archive › dc_d643370a4253

Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide — Europe PMC PMID:42422351

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42422351
DOI
10.1039/d5na01168j
License (as archived)
solo-consultazione
Archived
2026-11-01T09:17:38.453Z
SHA-256 of the archived text
97786ae630b8c3390662d04ccf64ab52fb409c5d26ba65673ba0e52f657e9d88
Stable URL of this page
https://metraipolis.com/documento/dc_d643370a4253

How to cite

Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide — Europe PMC PMID:42422351 — Europe PMC (en), https://europepmc.org/article/MED/42422351 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d643370a4253 (Metraipolis archive dc_d643370a4253, sha256 97786ae630b8c3390662d04ccf64ab52fb409c5d26ba65673ba0e52f657e9d88)
BibTeX
@misc{dcd643370a4253,
  title = {Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide — Europe PMC PMID:42422351},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42422351},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d643370a4253; sha256 97786ae630b8c3390662d04ccf64ab52fb409c5d26ba65673ba0e52f657e9d88},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42422351. Agents can read the archived copy with the MCP tool read_document.